FDA DEVICE FACTS
PATIENT SPECIFIC DISTAL FEMORAL
Stanmore Implants Worldwide , Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Patient Specific Distal Femur is intended for the replacement of diseased or deficient bone in the distal femur. It is indicated for:
• Limb salvage procedures where radical resection and replacement of the bone is required
• Painful and disabled joint resulting from avascular necrosis, osteoarthritis, rheumatoid arthritis or traumatic arthritis
• Correction of varus, valgus or post traumatic deformity
• Correction of revision of unsuccessful osteotomy, arthrodesis, or previous joint replacement
• Ligament deficiencies
• Tumor resection
• Revision of previously failed total joint arthroplasty
• Trauma
The Patient Specific Femur and its components are for single use only. The Patient Specific Distal Femur and its components are for cemented use only.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。